Kort præsentation

Jakob Seidelin has a medical degree (MD), a PhD and DMSc from University of Copenhagen and is a researcher at Rigshospitalet, University of Copenhagen. He is a consultant in Gastroenterology with focus on IBD. His main research interests are intestinal injury responses and intestinal damage with a focus on regenerative medicine in IBD. This includes clinical studies and translational in vivo and in vitro studies of the human intestinal mucosa. Further, Jakob Seidelin is national coordinator and PI on a number of investigator initiated and sponsor initiated controlled randomized trials in IBD.

Link to publication list from PubMed

Link to Google scholar profile

Jakob Seidelin er læge, dr. med. og ph.d. fra Københavns Universitet og forsker på Rigshospitalet/Institut for Klinisk medicin, KU.  Han er overlæge i gastroenterologi med fokus på IBD. Hans vigtigste forskningsinteresser er kliniske studier i svær IBD og translationelle studier i kroppens respons på tarmskade. Dette er hovedsageligt baseret på in vivo og in vitro-undersøgelser af den humane slimhinde. Endvidere er Jakob Seidelin national koordinator og PI for en række klinisk kontrollerede forsøg i IBD.

Link til publikationsliste på PubMed

Link til Google scholar-profil

CV

EDUCATION AND ACADEMIC TITLES

1998 MD^a, 2004 PhD^a, 2010 Specialist, 2015 DMSc^a

CURRENT POSITIONS

2024: Clinical researcher and Consultant Gastroenterologist at Rigshospitalet.

RESEARCH APPOINTMENTS

2022 – 2024        Professor of Gastroenterology, Herlev Hospital^a

2016 – 2022        Associate Research Professor, Herlev Hospital^a

2015                    Visiting scientist 4 months, the Langer Lab and The Karp Lab, MIT, Cambridge, MA, USA

2012 – 2015        Clinician scientist^b, 1:1 research:clinical work

2000 – 2003        PhD^a, “Apoptosis in IBD”

1994                   Student research fellow, Dept of Physiology^a, “Epilepsy models”

BOARD MEMBER

2024: SciCom, IBUS; 2017: Conference organizing committee, The Danish Society for Gastroenterology and Hepatology (DSGH). 2021: Gastrointestinal ultrasound committee, DSGH; 2015 – 2019: National representative, United European Gastroenterology. 2014 – 2015: Research Ethics Committee of the Capital Region. 2009 – 2013: The Danish Society of Medical Philosophy of Science and Ethics

SUPERVISION AND TEACHING

Supervision: 10 pre- and post-graduate students, 9 PhD students (4 primary supervisor, 3 primary co-supervisor). Teaching: Extensive pre- and postgraduate teaching within gastroenterology/immunology^a

NETWORK AND COMMUNICATION

Present main collaborators: Jeffrey Karp, M.I.T., MA, USA. Post. Doc. Johan Burisch, Hvidovre Hospital, Denmark, Professor Anders Woetmann, Dept. Immunology and Microbiology^a

EXPERT REVIEW, EVALUATION OF DOCTORAL DEGREES

Broad Medical Foundation, CA, USA; l’Agence Nationale de la Recherche, France; the National Czech Science Foundation; The Irish Research Council; Swiss National Science Foundation; First opponent, PhD thesis evaluation committee, University of Tromsø; Head of PhD thesis evaluation committees^a. Head of professor assessment committee^a. Head of DMSc evaluation committee.

PUBLICATIONS AND BIBLIOMETRICS

126 (PubMed), 4 book chapters, +50 oral/posters. Papers in top journals of the field: IF>40: Nat Rev Gastr Hepat; IF>20: Gastr, IF>10: Am J Gastr, Autophagy, Biomaterials, Clin Gastr Hepat, EMBO Mol Med, Int Care Med, Nature Com, Trends in Mol Med. H-index: 31 (Clarivate Analytics), 35 (Google Scholar)

CLINICAL RESEARCH

NC+PI of 7 RCTs. PI of 7 RCTs. Sub-I of 5 RCTs. Sponsor-investigator on 1 RCT

^aat UCPH

Full publication list: https://www.ncbi.nlm.nih.gov/myncbi/1FOt7CiBJai/bibliography/public/